ENvue Medical
4.02
--
--
NAOV
02-09 09:30:00(美东时间)
高
--
开
--
量
--
总市值
437.45万
低
--
换
--
额
--
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
ENvue Medical(NAOV)
2025-12-24 05:15
$ENvue Medical(NAOV)$
8-K Current report, items 5.02 and 9.01 Accession Number: 0001493152-25-029018 Act: 34 Size: 1 MB
网页链接
ENvue Medical(NAOV)
2025-12-19 19:15
$ENvue Medical(NAOV)$
EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003831 Act: 33 Size: 2 KB
网页链接
ENvue Medical(NAOV)
2025-12-19 06:45
$ENvue Medical(NAOV)$
3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-25-028388 Size: 3 KB
网页链接
ENvue Medical(NAOV)
2025-12-19 06:45
$ENvue Medical(NAOV)$
3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-25-028390 Size: 3 KB
网页链接
ENvue Medical(NAOV)
2025-12-19 06:05
$ENvue Medical(NAOV)$
424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-25-028374 Act: 33 Size: 202 KB
网页链接
ENvue Medical(NAOV)
2025-12-12 22:15
$ENvue Medical(NAOV)$
8-K Current report, items 5.03, 7.01, and 9.01 Accession Number: 0001493152-25-027380 Act: 34 Size: 247 KB
网页链接
ENvue Medical(NAOV)
2025-12-10 19:05
$NanoVibronix(NAOV)$
S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-25-026987 Act: 33 Size: 484 KB
网页链接
ENvue Medical(NAOV)
2025-12-05 19:25
$NanoVibronix(NAOV)$
8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001493152-25-026247 Act: 34 Size: 246 KB
网页链接
ENvue Medical(NAOV)
2025-11-19 21:05
$NanoVibronix(NAOV)$
8-K Current report, item 7.01 Accession Number: 0001493152-25-024167 Act: 34 Size: 245 KB
网页链接
ENvue Medical(NAOV)
2025-11-15 05:45
$NanoVibronix(NAOV)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-023542 Act: 34 Size: 6 MB
网页链接
ENvue Medical(NAOV)
2025-11-10 19:15
$NanoVibronix(NAOV)$
ARS Annual Report to Security Holders Accession Number: 0001493152-25-021357 Act: 34 Size: 2 MB
网页链接
ENvue Medical(NAOV)
2025-11-10 19:05
$NanoVibronix(NAOV)$
DEF 14A Other definitive proxy statements Accession Number: 0001493152-25-021353 Act: 34 Size: 4 MB
网页链接
ENvue Medical(NAOV)
2025-10-31 04:35
$NanoVibronix(NAOV)$
PRE 14A Other preliminary proxy statements Accession Number: 0001493152-25-020244 Act: 34 Size: 4 MB
网页链接
ENvue Medical(NAOV)
2025-10-31 04:15
$NanoVibronix(NAOV)$
8-K Current report, item 5.02 Accession Number: 0001493152-25-020214 Act: 34 Size: 200 KB
网页链接
ENvue Medical(NAOV)
2025-10-07 04:15
$NanoVibronix(NAOV)$
S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-25-017073 Act: 33 Size: 486 KB
网页链接
ENvue Medical(NAOV)
2025-09-18 04:15
$NanoVibronix(NAOV)$
8-K Current report, items 1.01 and 8.01 Accession Number: 0001493152-25-013881 Act: 34 Size: 696 KB
网页链接
ENvue Medical(NAOV)
2025-09-18 00:15
$NanoVibronix(NAOV)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001493152-25-013849 Act: 33 Size: 502 KB
网页链接
ENvue Medical(NAOV)
2025-09-16 05:15
$NanoVibronix(NAOV)$
S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-25-013524 Act: 33 Size: 478 KB
网页链接
ENvue Medical(NAOV)
2025-08-20 05:15
$NanoVibronix(NAOV)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001641172-25-024854 Act: 34 Size: 6 MB
网页链接
ENvue Medical(NAOV)
2025-08-15 04:15
$NanoVibronix(NAOV)$
NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001641172-25-023997 Act: 34 Size: 31 KB
网页链接